1. Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy.
- Author
-
Motte J, Grüter T, Fisse AL, Bulut Y, Stykova Z, Greiner T, Enax-Krumova E, Yoon MS, Gold R, Tegenthoff M, Sturm D, and Pitarokoili K
- Subjects
- Adult, Aged, Cohort Studies, Cornea immunology, Cornea pathology, Disease Progression, Electromyography, Female, Humans, Male, Microscopy, Confocal methods, Middle Aged, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating immunology, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating physiopathology, Prognosis, Prospective Studies, Cornea diagnostic imaging, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating diagnostic imaging
- Abstract
The assessment of disease activity is fundamental in the management of chronic inflammatory demyelinating polyneuropathy (CIDP). Previous studies with small patient numbers found an increase of corneal immune cell infiltrates as a potential marker of inflammation in patients with CIDP. However, its clinical relevance remained unclear. The present study aimed to determine whether the amount of corneal inflammatory cells (CIC) measured by corneal confocal microscopy (CCM) detects disease activity in CIDP. CIC were measured in 142 CCM-investigations of 97 CIDP-patients. Data on clinical disease activity, disability (INCAT-ODSS) and need for therapy escalation at the timepoint of CCM, 3 and 6 months later were analyzed depending CIC-count. Pathological spontaneous activity during electromyography was examined as another possible biomarker for disease activity in comparison to CIC-count. An increased CIC-count at baseline was found in patients with clinical disease activity and disability progression in the following 3-6 months. An increase to more than 25 CIC/mm
2 had a sensitivity of 0.73 and a specificity of 0.71 to detect clinical disease activity and a sensitivity of 0.77 and a specificity of 0.64 to detect disability progression (increasing INCAT-ODSS) in the following 6 months. An increase to more than 50 CIC/mm2 had a sensitivity of about 0.51 and a specificity of 0.91 to detect clinical disease activity and a sensitivity of 0.53 and a specificity of 0.80 to detect disability progression. CIC count is a non-invasive biomarker for the detection of disease activity in the following 6 months in CIDP., (© 2021. The Author(s).)- Published
- 2021
- Full Text
- View/download PDF